Tender notice from Bulgaria, published on 02 Nov 2018.
Executive Summary
The „?????????? ??????????? ?????? — ?????? ???????“ ???? has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 02 Nov 2018 and is scheduled to close on 19 Nov 2018, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 28165417, while the tender notice number is 481709-2018 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Other Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33600000, 33600000 CPV Description: Pharmaceutical products - Delivery of pharmaceuticals and radiopharmaceuticals for the needs of "KOT - V. Tarnovo" Ltd. Reference Number: 00763 Supply of drugs and radiopharmaceuticals for diagnostics and therapy of patients with oncological diseases in "KOTS - V. Tarnovo "Ltd. Main Site: Hospital Pharmacy of" KOTS - V. Tarnovo "EOOD Supply of medicines, item no. 1, distributionin 36 pharmacological groups with a total of 256 nos. units: 1. Anesthetics - 1-13 Nom. 2. Analgesics - narcotics, non-narcotics and antipyretics - 14-21 nos. 3. Psychoeptics - 22-27 Nom. 4. Nootropic - 28 - 29 Nom. 5. Parasympathicomimetics - 30 ng. 6. Drugs for treatment of peptic ulcer - H2 receptor antagonists, proton pump inhibitors - 31-33 ng-7. Spasmolytic and anticholesnerve agents and preparations for strengthening the peristalsis - 34-42 nos. 8. Treatment of liver - 43-45 nos. 9. Purifying agents - 46, 47 nom. 10. Antidiarrheal intestinal contraceptives inhibiting peristalsis - 48, 49 nos. 11. One-Crown Metabolic Preparations, Human Insulin - 50 Nom. 12. Vitamins - 51-58 Nom. 13. Mineral supplements - 59-63 Nom. 14. Add-ons for intravenous infusionsbut application - 64 nom. 15. Antithrombotic vitamin A-antagonists. K and the group of heparin - 65-76 nos. 16. Anti-hemorrhoids - 77-79 nos. 17. Antianemic Preparations and Colony Stimulating Factors - 80-84 Nom. 18. Plasma substitutes and infusion, colloid solutions - 85-113 nos. 19. Treatment of heart disease - 114-138 nos. 20. Diuretics - 139-144 ng. 21. Perryferret vasodilators - 145-147 nm 22. Dermatological remedies - 148-161 ng. 23. Corticosteroids - 162-168 nm 24. Antibacterial agents - 169-214 nos. 25. Non-steroidal anti-inflammatory drugs - 215-220 nos. 26. Miorelaxants - 221-225 nos. 27. Anti-asthmatic preparations - 226-231 nos. 28. Drugs for cough and colds - 232-235 nos. 29. Antihistamines-preparations - 236-238 nos. 30.Other help. products - 239 Nom. 31. X-ray contrast media - 240-243 nm 32. Eating Food - 244-248 Nom. 33. Serum and immunoglobulin preparations and vaccines - 249-250 ng. 34. Avg. affecting calcium and phosphorus and bone metabolism - 251 nM 35. Antidotes - 252-254 nos. 36. Other Drugs - 255 and 256. Full Nameand the estimated number of participants can be found at: http: //www.onkologyvt.com/procurments/23102018-2/.- The designated contractor for Sevofluran fl. 250 ml is obliged: - to provide free of charge for the term of the contract evaporators with closed filling system without adapter, compatible with the available equipment in the Ministry of Health, - to submit a technical protocol for the safety of the working environment - Participants must hold a valid permit for wholesale trade of medicinal products issued by the BDA on the basis of LMPHM and for foreign persons an equivalent document according to their national legislation. To prove the fitness criterion (capacity)the participants on request and the contractor selected before the contract is awarded a valid authorization to carry out wholesale trade in medicinal products or an equivalent document according to the legislation of the country where the participant is established (for foreign participants). For the participants in the procedure, the circumstances under Art. 54 and-Art. 55, para. 1, item 1 of the Public Procurement Act. Otherwise, they are removed from participation. They shall declare the lack of grounds for removal under Art. 54 and Art. 55, para. 1, item 1 of the Public Procurement Act through the presentation of the eEEDOP when submitting its tender. In case the participant has the circumstance under Art. 55, para. 1, item 1 of the Public Procurement Act, it may not be removed if it is proved that it has not ceased its activity and is incondition to perform the order. Existence or absence of the circumstances for removal under Art. 159 a-159 d, Art. 192 a, Art. 209, Art. 253, Art. 301-307, Art. 321 and 321a of the Criminal Code are declared in section A "Grounds relating to criminal convictions" in Part III "Grounds for exclusion" in the enEEDOP. The presence or absence of the circumstances for removal under Art. 108a, Art. 172, Art. 194-217, Art. 219-252, -Art. 352-353 is, Art. 254-260 of the Penal Code is declared in Part D "Other grounds for exclusion that may be provided for under the national law of the contracting authority or the contracting authority of a Member State" in Part III "Grounds for exclusion" in the EDEDDO. The performance guarantee is 2% of the contract value excluding VAT. The same shall be presented in one of the forms under Art. 111, para. 5 of the Public Procurement Act. Bank Guaranteethe insurance and the insurance have a validity term of 1 month after the term of the contract and the monetary guarantee is deposited on the following bank account: IBAN BG 52 UNCR 9660 10 37 299 411 BIC: UNCRBGSF, Unicredit Bulbank AD, Veliko Tarnovo Branch. for the release of the performance guarantee are settled in the contract for the award of the contract.of the offers under Art. 104, para. 2 of the Public Procurement Act and Art. 61 of the PPP Internet address (URL): www.onkologyvt.com
The bid deadline for Contract notice: Pharmaceutical products was 19 Nov 2018. Bidding is closed.
This tender has been issued by „?????????? ??????????? ?????? — ?????? ???????“ ???? in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 28165417. The purchaser document reference is 481709-2018.